公司資料

Y-mAbs 股價、新聞與催化劑

股票代碼:: YMAB
交易所:: NASDAQ
產業:: Biopharma
所在地:: United States

股價為何變動

Current closing-price context is not available for YMAB.

公司概覽

業務概覽

Y-mAbs Therapeutics is an oncology and rare-disease company focused on antibody-based therapies. Its platform has been built around highly specific biologic treatments for difficult diseases.

所在地與產業分類

Headquartered in the United States and listed on NASDAQ, Y-mAbs sits in specialty biotechnology.

商業模式特徵

The company depends on product adoption, clinical progress, and the expansion of its antibody franchise.

生技產業定位

Y-mAbs is a focused antibody biotech whose stock reacts to data, adoption, and label progress.

未來催化劑

Y-mAbs’s catalysts are DANYELZA sales, pediatric-oncology expansion, and any follow-on immunotherapy update. The key question is whether the GD2 franchise can keep compounding.